158 related articles for article (PubMed ID: 5021874)
1. [Functional cardio-respiratory aspects of scleroderma].
Morpurgo M; Rampulla C; Beulcke G; Casaccia M; Finardi G; Venco A
Schweiz Med Wochenschr; 1972 Apr; 102(17):605-11. PubMed ID: 5021874
[No Abstract] [Full Text] [Related]
2. [Diffusion disorders in patients with scleroderma].
Konietzko N; Carton RW
Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(3):196-205. PubMed ID: 5801289
[No Abstract] [Full Text] [Related]
3. [The respiratory system in scleroderma: radiological study].
Pompili G; Alè G; Generalità I
Nunt Radiol; 1968 Oct; 34(10):1053-80. PubMed ID: 5745106
[No Abstract] [Full Text] [Related]
4. [Pulmonary changes in diffuse scleroderma in the radiologic and pneumonologic picture].
Dolinský A
Vnitr Lek; 1979 Nov; 25(11):1127-30. PubMed ID: 516494
[No Abstract] [Full Text] [Related]
5. [The clinical and roentgenologic picture of pulmonary changes in systemic sclerosis].
Presetnik M; Music E; Rozman B
Plucne Bolesti; 1988; 40(3-4):118-20. PubMed ID: 3252291
[No Abstract] [Full Text] [Related]
6. Upper gastrointestinal functions in progressive systemic sclerosis (PSS).
Deodhar SD; Tyagi SK; Nath IV; Dilawari JB
J Assoc Physicians India; 1982 Jun; 30(6):365-7. PubMed ID: 7169452
[No Abstract] [Full Text] [Related]
7. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
8. Single-breath pulmonary diffusing capacity. Reference values and application in connective tissue diseases and in various lung diseases.
Salorinne Y
Scand J Respir Dis Suppl; 1976; 96():1-84. PubMed ID: 1076826
[TBL] [Abstract][Full Text] [Related]
9. Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis.
Peters-Golden M; Wise RA; Schneider P; Hochberg M; Stevens MB; Wigley F
Medicine (Baltimore); 1984 Jul; 63(4):221-31. PubMed ID: 6738343
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
[TBL] [Abstract][Full Text] [Related]
11. Serial changes in scleroderma and idiopathic interstitial lung disease.
Colp CR; Riker J; Williams MH
Arch Intern Med; 1973 Oct; 132(4):506-15. PubMed ID: 4742404
[No Abstract] [Full Text] [Related]
12. [Raynaud's syndrome--main symptom of progressive systemic sclerosis (sclerodermia)].
Krull P; Alexander K; Fabel H; Ostertag H; Wagner HH; Deicher H
Med Klin; 1972 Mar; 67(10):332-7. PubMed ID: 5022240
[No Abstract] [Full Text] [Related]
13. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.
Owens GR; Fino GJ; Herbert DL; Steen VD; Medsger TA; Pennock BE; Cottrell JJ; Rodnan GP; Rogers RM
Chest; 1983 Nov; 84(5):546-50. PubMed ID: 6628005
[TBL] [Abstract][Full Text] [Related]
14. [Roentgenmorphologic findings in scleroderma].
Kauffmann GW; Reinbold WD; Hagedorn M
Rofo; 1983 May; 138(5):607-13. PubMed ID: 6221980
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the lungs in progressive systemic scleroderma].
Georgiev O; Marinov Kh; Rashkov R; Shoshkov P
Vutr Boles; 1991; 30(2):51-5. PubMed ID: 1891899
[TBL] [Abstract][Full Text] [Related]
16. [Pulmonary function in scleroderma].
Romeiro Neto M; Barbas Filho JV; Vargas FS; Varrastro C; Cukier A; Onishi R; Cossermelli W
Rev Hosp Clin Fac Med Sao Paulo; 1980 Aug; 35(4):178-82. PubMed ID: 7455500
[No Abstract] [Full Text] [Related]
17. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline.
Plastiras SC; Karadimitrakis SP; Ziakas PD; Vlachoyiannopoulos PG; Moutsopoulos HM; Tzelepis GE
Arthritis Rheum; 2006 Aug; 55(4):598-602. PubMed ID: 16874782
[TBL] [Abstract][Full Text] [Related]
18. [Studies of the respiratory function in scleroderma. Report on 5 cases].
Martínez Guerra L; Fernández Bonetti P; Balvanera Abreu A; Varela Carrillo M; Soní Cassani J
Arch Inst Cardiol Mex; 1971; 41(5):525-30. PubMed ID: 5131720
[No Abstract] [Full Text] [Related]
19. Evaluation of the functional parameters in scleroderma cases with pulmonary involvement.
Celebi Sözener Z; Karabıyıkoğlu G; Düzgün N
Tuberk Toraks; 2010; 58(3):235-41. PubMed ID: 21038133
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary function tests.
Behr J; Furst DE
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
